Liver histopathology in human immunodeficiency virus-hepatitis C virus co-infected patients with fatal liver disease

Journal of Gastroenterology and Hepatology (Australia)

Volumn 20, Issue 5, 2005, Pages 739-745

  Lichterfeld, Mathias ^a,b   Haas, Susanne ^a   Fischer, Hans Peter ^a   Voigt, Ester ^a   Rockstroh, Jürgen K ^a   Spengler, Ulrich ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Bilirubinostasis; Cholestasis; HIV HCV co infection; Liver histopathology

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; CD4 ANTIGEN; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; SAQUINAVIR; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CAUSE OF DEATH; CHRONIC HEPATITIS; CLINICAL ARTICLE; COMORBIDITY; CONTROLLED STUDY; DETERIORATION; FATALITY; HEPATITIS C; HEPATITIS C VIRUS; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LYMPHOCYTE COUNT; PRIORITY JOURNAL; PROGNOSIS;

EID: 19544382720     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2005.03750.x     Document Type: Article

References (24)

1. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J. Acquir. Immunodefic. Syndr. 1993; 6: 602-10.
2. Rockstroh JK, Spengler U, Sudhop T et al. Immunosuppression may lead to progression of hepatitis C virus-associated liver disease in hemophiliacs coinfected with HIV. Am. J. Gastroenterol. 1996; 91: 2563-8.
3. Eyster ME, Fried MW, Di Bisceglie AM, Goedert JJ. Increasing hepatitis C virus RNA levels in hemophiliacs: relationship to human immunodeficiency virus infection and liver disease. Multicenter Hemophilia Cohort Study. Blood 1994; 84: 1020-3.
4. Matthews-Greer JM, Caldito GC, Adley SD et al. Comparison of hepatitis C viral loads in patients with or without human immunodeficiency virus. Clin. Diagn. Lab. Immunol. 2001; 8: 690-4.
5. Sulkowski MS, Mast EE, Seeff LB, Thomas DL. Hepatitis C virus infection as an opportunistic disease in persons infected with human immunodeficiency virus. Clin. Infect. Dis. 2000; 30 (Suppl. 1): S77-84.
6. Rockstroh JK, Theisen A, Kaiser R, Sauerbruch T, Spengler U. Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs. AIDS 1998; 12: 829-30.
7. Rutschmann OT, Negro F, Hirschel B, Hadengue A, Anwar D, Perrin LH. Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J. Infect. Dis. 1998; 177: 783-5.
8. Ragni MV, Belle SH. Impact of human immunodeficiency virus infection on progression to end-stage liver disease in individuals with hemophilia and hepatitis C virus infection. J. Infect. Dis. 2001; 183: 1112-15.
9. Yokozaki S, Takamatsu J, Nakano I et al. Immunologic dynamics in hemophiliac patients infected with hepatitis C virus and human immunodeficiency virus: influence of antiretroviral therapy. Blood 2000; 96: 4293-9.
10. Bierhoff E, Fischer H, Willsch E et al. Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection. Virchows Arch. 1997; 430: 271-7.
11. Pol S, Fontaine H, Carnot F et al. Predictive factors for development of cirrhosis in parenterally acquired chronic hepatitis C: a comparison between immunocompetent and immunocompromised patients. J. Hepatol. 1998; 29: 12-19.
12. Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J. Hepatol. 1995; 22: 696-9.
13. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am. J. Gastroenterol. 1999; 94: 2467-74.
14. Puoti M, Bonacini M, Spinetti A et al. Liver fibrosis progression is related to CD4 cell depletion in patients coinfected with hepatitis C virus and human immunodeficiency virus. J. Infect. Dis. 2001; 183: 134-7.
15. Di Martino V, Rufat P, Boyer N et al. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology 2001; 34: 1193-9.
16. Spengler U, Lichterfeld M, Rockstroh JK. Antiretroviral drug toxicity: a challenge for the hepatologist? J. Hepatol. 2002; 36: 283-94.
17. Scheuer PJ, Lefkovitch JH. Liver Biopsy Interpretation, 5th edn. London: WB Saunders, 1994.
18. Triger DR, Preston FE. Chronic liver disease in haemophiliacs. Br. J. Haematol. 1990; 74: 241-5.
19. Cotler SJ, Taylor SL, Gretch DR et al. Hyperbilirubinemia and cholestatic liver injury in hepatitis C-infected liver transplant recipients. Am. J. Gastroenterol. 2000; 95: 753-9.
20. Schluger LK, Sheiner A, Thung SN et al. Severe recurrent cholestatic hepatitis C following orthotopic liver transplantation. Hepatology 1996; 23: 971-6.
21. Rosenberg PM, Farrell JJ, Abraczinskas DR, Graeme-Cook FM, Dienstag JL, Chung RT. Rapidly progressive fibrosing cholestatic hepatitis: hepatitis C virus in HIV coinfection. Am. J. Gastroenterol. 2002; 97: 478-83.
22. Tolan DJ, Davies MH, Millson CE. Fibrosing cholestatic hepatitis after liver transplantation in a patient with hepatitis C and HIV infection. N. Engl. J. Med. 2001; 345: 1781.
23. Lim HL, Lau GK, Davis GL, Dolson DJ, Lau JY. Cholestatic hepatitis leading to hepatic failure in a patient with organ-transmitted hepatitis C virus infection. Gastroenterology 1994; 106: 248-51.
24. Deshpande V, Burd E, Aardema KL et al. High levels of hepatitis C virus RNA in native livers correlate with the development of cholestatic hepatitis in liver allografts and a poor outcome. Liver Transpl. 2001; 7: 118-24.